<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "fluorouracil inj VIAL">
<dose><value>500</value>
</dose>
<route><value>IV</value>
</route>
<strength><value>50 mg/mL</value>
</strength>
<frequency><value>ONCE</value>
</frequency>
<instruction><value>DAY 1 of 21. Administer by direct injection over 1 to 2 minutes.</value>
<value>DAY 1 of 21. Administer dose diluted in 0.9% sodium chloride 100 mL over 15 minutes.</value>
</instruction>
<volume><value>100 mL</value>
</volume>
<units><value>mg/m2</value>
</units>
<Population><value>Fluorouracil, Epirubicin, Cyclophosphamide (FEC) followed by DOCEtaxel. Breast Cancer (NEOADJUVANT Treatment).</value>
<value>Fluorouracil, Epirubicin, Cyclophosphamide (FEC) followed by DOCEtaxel &amp; Trastuzumab</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>If ANC is greater than or equal to 1.5 AND Plts are greater than or equal to 100 x 109/L: Give as ordered. If ANC is less than 1.5 OR Plts are less than 100 x 109/L: Delay 1 week.</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3393</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus></AHSFormularyStatus>
<HighAlert><value>HIGH ALERT MEDICATION</value>
</HighAlert>
</drug>